NASDAQ:LMAT
Lemaitre Vascular Inc.
Lemaitre Vascular Inc.'s revenue grew 13.5% in fiscal 2025 to $249.6M while operating margin rose to 27.2%, its highest in 10 years. Free cash flow was $74.5M, 29.8% of revenue, and the diluted share count rose 0.7%.Summary generated from Lemaitre Vascular Inc.'s SEC filings. Latest annual report filed Feb 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$249.6M
Revenue growth+13.5%
Revenue, 5-yr CAGR+14.0%
Gross margin71.5%
Operating margin27.2%
Net margin23.1%
ROICn/a
Return on equity15.8%
Debt / equityn/a
Free cash flow$74.5M
FCF margin29.8%
Share count change+0.7%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 154 | 162 | 193 | 220 | 250 |
| Operating income | 36 | 27 | 37 | 52 | 68 |
| Net income | 27 | 21 | 30 | 44 | 58 |
| Free cash flow | 30 | 22 | 29 | 37 | 74 |
Recent filings
- 4Insider transaction report
Sep 8, 2026 - 4Insider transaction report
Sep 8, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 4, 2026 - 8-KResults of a shareholder vote
Jun 5, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 6, 2026 - 8-KResults of operations and financial condition
May 5, 2026 - DEF 14AProxy statement
Apr 14, 2026